Overmyer Network

Renowned Transplant Surgeon and Medical Innovator, Dr. Robert Mendez, Remembered for Lifelong Dedication to Advancing Organ Donation and Transplantation

Retrieved on: 
Tuesday, April 2, 2024
Science, Research, Surgery, General Health, Health, Hospitals, Philanthropy, Foundation, UNOS, Foreign policy, Organ transplantation, Surgeon, Sharp HealthCare, Transplant, Education, Keck Hospital of USC, Knowledge, University, Kidney transplantation, General surgery, Death, MD, Parliament, Overmyer Network, St. Vincent's Hospital, Stanford University, Bangladesh Technical Education Board, Multimedia, Family, MNIT, Flower, Medicine, Dentistry

Along with his twin brother, Dr. Rafael Mendez, Dr. Robert Mendez was a worldwide pioneer in kidney transplantation and organ donation, who revolutionized the field with his expertise and dedication.

Key Points: 
  • Along with his twin brother, Dr. Rafael Mendez, Dr. Robert Mendez was a worldwide pioneer in kidney transplantation and organ donation, who revolutionized the field with his expertise and dedication.
  • View the full release here: https://www.businesswire.com/news/home/20240401597673/en/
    From Left to Right: Dr. Rafael Mendez and Dr. Robert Mendez, organ donation and transplantation pioneers.
  • (Photo: Business Wire)
    Born on March 2, 1937, Dr. Robert Mendez embarked on a remarkable career that spanned over four decades.
  • Dr. Robert Mendez’s impact on the world of organ transplantation, organ donation and medicine at large are immeasurable.

Midwest Transplant Network Surpasses Expectations to Save and Enhance Lives in 2023

Retrieved on: 
Monday, February 5, 2024
Partnership, Haematopoietic system, CCRN, DCU, ACHI, ASCP, Hospital, Patient, Transplant, MSN, Overmyer Network, OPO, Urinalysis, Hope, MTN, Eye, RN, Operating, Dentistry

“What we achieved at Midwest Transplant Network in 2023 reflects the commitment of the staff who do the work every day to support organ donation and transplantation.

Key Points: 
  • “What we achieved at Midwest Transplant Network in 2023 reflects the commitment of the staff who do the work every day to support organ donation and transplantation.
  • The work is hard, and happens in countless ways, but we are all dedicated to the mission of enhancing and saving lives through organ, eye and tissue donation” said Jan Finn, RN, MSN, President & CEO, Midwest Transplant Network.
  • The United Network for Organ Sharing reported that across the country, clinical workers performed more than 46,000 lifesaving transplants in 2023.
  • Incorporated in 1973, Midwest Transplant Network facilitates organ, eye and tissue donation in partnership with hospitals and other professional partners to give hope and share life.

Medeor Therapeutics Announces Interim Data from Pivotal Trial Showing Cell Therapy Technology Could Eliminate Life-Long Need for Immunosuppressant Drugs Following Kidney Transplant

Retrieved on: 
Thursday, November 2, 2023
Biotechnology, Surgery, Health, Pharmaceutical, Clinical Trials, Survival, FDA, Standard of care, Regenerative Medicine Advanced Therapy, IND, Number needed to treat, Kidney disease, Stanford University, Immune tolerance, United Network for Organ Sharing, Diabetes, CTA, Infection, Kidney, Mental health, Cell, Jan Vansina, Society, Control, American Society of Nephrology, Quality of life, Clinical trial, ASN, Risk, Annual general meeting, Overmyer Network, Blood, University, Depression, Cancer, Anxiety, Therapy, SPA, Patient, Death, Immunosuppression, Transplant, Rheumatology, Protein toxicity, Pharmaceutical industry, Dentistry, Medical device, EU

Kidney transplant recipients who received a living donor kidney from an HLA-matched relative achieved functional tolerance and were free from the regimen of immunosuppressive drugs.

Key Points: 
  • Kidney transplant recipients who received a living donor kidney from an HLA-matched relative achieved functional tolerance and were free from the regimen of immunosuppressive drugs.
  • Typically, these drugs are required to prevent rejection and failure of the kidney transplant.
  • Study results will be presented during a late-breaking oral presentation at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting.
  • Following a kidney transplant, patients today are required to take daily immunosuppression medications for the rest of their lives to prevent rejection of the transplanted kidney.

Randall C. Starling, MD, MPH Receives 2023 HFSA Lifetime Achievement Award for His Contributions to the Field of Heart Failure

Retrieved on: 
Thursday, September 14, 2023
Cleveland Clinic, Vice, University, Alpha and Omega, Heart failure, Education, Internal medicine, Temple University, Heart Failure Society of America, Lung transplantation, NIH, American College of Cardiology, Case Western Reserve University, Research, Journal of Cardiac Failure, Alpha Omega Alpha, National Institutes of Health, Associate, Bangladesh Technical Education Board, Science, OSU, University of Pittsburgh Medical Center, Public health, Journal, Publishing, Overmyer Network, Scientific programming language, Cardiology, Huntington Convention Center of Cleveland, Master, Biology, American College, MPH, Wilfrid Sellars, International Society, Medical device, Dentistry, MD, Medicine

The award will be presented to Dr. Starling at the HFSA Annual Scientific Meeting on Saturday, October 7 in Cleveland, Ohio.

Key Points: 
  • The award will be presented to Dr. Starling at the HFSA Annual Scientific Meeting on Saturday, October 7 in Cleveland, Ohio.
  • As an internationally recognized pioneer and expert in the field of heart failure, this prestigious award will pay tribute to his exemplary career in heart failure research, publishing, mentorship and leadership.
  • Dr. Starling served as President of HFSA in 2018-2019 and has been an active member since its inception in 1995.
  • Dr. Starling joins an elite list of current and past Lifetime Achievement Award winners with this year's recognition.

Thermo Fisher Scientific Selected as the Transplantation Statistical and Clinical Coordinating Center (T-SCCC) for the U.S. National Institute of Allergy and Infectious Diseases

Retrieved on: 
Thursday, August 10, 2023
Infectious Diseases, Health, Clinical Trials, United States Department of Health and Human Services, National Institute of Allergy and Infectious Diseases, United Network for Organ Sharing, PPD, Maintenance, U.S. Department of Defense Strategy for Operating in Cyberspace, Human services, Office of Inspector General, U.S. Department of Health and Human Services, Quality of life, Research, Thermo Fisher Scientific, Bangladesh Technical Education Board, Science, Transplant, CLIA, Patient, Manuscript, Overmyer Network, Kidney, Federation, NIAID, Plasma protein binding, Mindful Scientific Inc., Infection, Pharmaceutical industry, Dentistry

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been granted a five-year award to provide a Transplantation Statistical and Clinical Coordinating Center for the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health in the United States.

Key Points: 
  • The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been granted a five-year award to provide a Transplantation Statistical and Clinical Coordinating Center for the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health in the United States.
  • This center will offer a broad range of support services critical to the design, development, execution and analysis of NIAID transplantation clinical trials and research.
  • Thermo Fisher’s PPD clinical research business has three decades of experience successfully delivering clinical research services to governmental agencies, contractors and nonprofits.
  • The content of this announcement is solely the responsibility of Thermo Fisher Scientific and does not necessarily represent the official views of the National Institutes of Health.

Dr. Jose Garcia Joins Memorial Cardiac and Vascular Institute

Retrieved on: 
Wednesday, July 12, 2023
Heart, United Network for Organ Sharing, Indiana University, University, Memorial Hermann Health System, Surgery, Harvard University, Cardiovascular disease, ECMO, Funding of science, Research, University of Maryland Medical Center, MD, Patient, Memorial, Overmyer Network, Surgeon, Kidney transplantation, Consumer, UNOS, Federation, Methodist Hospital, Massachusetts General Hospital, MCS, Dentistry, Nursing, Medical device

HOLLYWOOD, Fla., July 12, 2023 /PRNewswire-PRWeb/ -- Jose P. Garcia, MD, a Harvard-educated and fellowship-trained cardiothoracic surgeon, has been named Chief of the Adult Heart Transplant Surgery and Mechanical Circulatory Support programs at Memorial Healthcare System. A longtime educator, Garcia has held leadership positions at multiple institutions, including Indiana University (Methodist Hospital), Harvard University (Massachusetts General Hospital), and the University of Maryland Medical Center.

Key Points: 
  • "Memorial's Cardiac and Vascular Institute is one of only two facilities in South Florida performing adult heart transplants and is known to deliver excellent outcomes.
  • At Memorial's Cardiac and Vascular Institute, Dr. Garcia will pair with Dr. I-wen Wang , the Surgical Chief of ECMO services.
  • The Memorial Cardiac & Vascular Institute is a cardiovascular care leader, offering a wide array of services dedicated to the prevention, detection, and treatment of cardiovascular disease.
  • With its extraordinary medical expertise, advanced technology, and exacting quality guidelines, Memorial Cardiac & Vascular Institute has earned a reputation for superior cardiovascular care.

Research Reveals Novel Insights into Transplant Rejection and New Drug Development Targets

Retrieved on: 
Wednesday, June 28, 2023
Weapon, United Network for Organ Sharing, Kidney transplantation, Surgeon, Tacrolimus, University, Biopsy, Union Christian College, Aluva, Diabetes, Half-life, Urine, Infection, Survival, Everolimus, Clinical trial, Research, Gene expression, Cincinnati Children's Hospital Medical Center, RNA, Cell, Doctor of Philosophy, JCI, TCR, Dialysis, B cell, Lung transplantation, Journal, CD8, Novartis, MD, UC, Smouldering, Journal of Clinical Investigation, Patient, University of Cincinnati, Division, Immune system, Overmyer Network, Kidney, UNOS, Liver, Injury, Notre Dame, Transplant, Health, Women's Choice Awards, Gene, People's Choice Awards, Dentistry, Pharmaceutical industry, Vaccine, Medical device, Gene Woodling

CINCINNATI, June 28, 2023 /PRNewswire/ -- Imagine a day when a urine test could inform a doctor precisely why a kidney transplant patient was experiencing organ rejection and suggest the best medication for specifically addressing the problem.  

Key Points: 
  • Findings suggests that multiple organ rejection events may actually be one, longer, smoldering rejection event.
  • "Having a precision-medicine approach to treating organ rejection has the potential to markedly reduce the threat rejection poses to transplanted organs," Woodle says.
  • However, once a kidney transplant recipient experiences acute rejection, many go on to lose their transplant and return to dialysis within 1-3 years.
  • "Thanks to insights like these, we may be able to substantially reduce loss of transplanted organs to rejection, thereby freeing up donated organs for new transplant recipients."

Memorial Transplant Institute's Kidney Program Seeks Living Donors

Retrieved on: 
Monday, April 17, 2023
Linda, Heart, Surgeon, Memorial Hermann Health System, Urine, National Kidney Registry, Oxygen, Dialysis, Pain, Transplant, National Kidney and Transplant Institute, Human, Memorial Regional Hospital (Florida), Overmyer Network, Risk, Memorial, Disease, Kidney, Mortality, Hospital, United Network for Organ Sharing, Kidney disease, Dentistry, Pharmaceutical industry, UNOS

HOLLYWOOD, Fla., April 17, 2023 /PRNewswire-PRWeb/ -- In its five-year history, Memorial Healthcare System's kidney transplant program has directly impacted more than 300 lives through both deceased donor and live donor kidney transplants. While deceased donor rates have been increasing, doctors say the number of live donor transplants could be exponentially higher if individuals in South Florida understood how they could help fill an unmet need.

Key Points: 
  • HOLLYWOOD, Fla., April 17, 2023 /PRNewswire-PRWeb/ -- In its five-year history, Memorial Healthcare System's kidney transplant program has directly impacted more than 300 lives through both deceased donor and live donor kidney transplants.
  • Just 41 of the 309 kidneys that have been transplanted at Memorial have come from living donors.
  • "A kidney coming from a living donor lasts two to three time longer than one procured from a person that recently died," said Dr. Linda Chen, a kidney transplant surgeon and surgical director of Memorial Healthcare System's Living Donor and Pediatric Abdominal Transplant program.
  • With approval from UNOS (United Network for Organ Sharing), Memorial Healthcare System launched its pediatric heart transplant program (2010), adult heart transplant program (2014, under the Memorial Cardiac and Vascular Institute banner), and the adult and pediatric kidney transplant program (2017).

MIT Sloan School of Management researchers help redesign national lung transplant allocation system using data analytics

Retrieved on: 
Tuesday, March 28, 2023
Database, Boeing, INFORMS Journal on Applied Analytics, Rib cage, OPTN, Human services, Policy, United Network for Organ Sharing, MIT Sloan School of Management, Intelligence, Research, MIT, Doctor of Philosophy, Lung, Death, Student, Patient, Machine learning, Organ, Artificial intelligence, UNOS, Liver, Management, Transplant, Dentistry, Medical device, Overmyer Network

CAMBRIDGE, Mass., March 28, 2023 /PRNewswire/ -- United Network for Organ Sharing (UNOS) has rolled out a new organ allocation system designed to be more equitable and effective for patients in need of lung transplants.

Key Points: 
  • As of March 9, 2023, all donated lungs across the US are allocated based on a new policy, developed with the assistance of researchers from MIT Sloan School of Management.
  • The policy change is predicted to reduce overall deaths and increase access for many patients waiting for a lung transplant.
  • Data for candidates seeking a deceased-donor transplant are maintained by UNOS in its role as the OPTN, the nation's organ transplant system.
  • "This means that the transplant system can be more fair, more efficient and more flexible for the entire patient population."

LiveOnNY and MediGO Collaborate to Launch Groundbreaking Real-Time Organ Tracking Technology to Increase Transparency and Accountability Within the Organ Donation and Transplant Ecosystem

Retrieved on: 
Friday, March 24, 2023
OPO, Elia del Medigo, United Network for Organ Sharing, Communication, GPS, Life, Eye, Innovation system, Multimedia, Transplant, Hospital, Patient, Overmyer Network, ANP, Machine learning, RN, UNOS, Growth, City, Edison Awards, Pharmaceutical industry, Online shopping

This unprecedented growth necessitated the need for better ways of effectively moving these lifesaving organs to those in need.

Key Points: 
  • This unprecedented growth necessitated the need for better ways of effectively moving these lifesaving organs to those in need.
  • A total of 48% of 1,300 gifted organs were transported out of the LiveOnNY Federally Designated Service Area in 2022.
  • LiveOnNY is a member of the United Network for Organ Sharing (UNOS), which oversees the organ transplant waiting list in the U.S. For more information, please visit LiveOnNY.org.
  • MediGO 's innovative healthcare supply chain technology digitally orchestrates the U.S. organ donation and transplant system to improve fairness and equity, reduce nonuse of donated organs, and save more lives.